Richard Stone, MD | Authors

US Oncology

20 Partridge View Lane

Wrentham

02093

Articles

When Imatinib Fails

April 15, 2008

The management of patients with chronic myelogenous leukemia (CML) has been altered dramatically since the introduction of tyrosine kinase inhibitors by Druker et al in the late 1990s.